首页> 外文期刊>International Journal of Molecular Epidemiology and Genetics >Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma
【24h】

Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma

机译:血浆可溶性受体,用于晚期糖基化终产物和结直肠腺瘤的风险

获取原文
           

摘要

Receptor for advanced glycation end products (RAGE) plays an important role in promoting chronic inflammation with activation of NF-κB. Soluble form of RAGE (sRAGE) represents a naturally occurring competitive inhibitor of RAGE-mediated events. In a colonoscopy-based case-control study, we examined the associations of plasma levels of sRAGE, sTNF-αRI, sTNF-αRII, sIL-6R, EGF, IFNα2, G-CSF, MCP1, TNFβ, and VEGF with risk of colorectal adenoma. We prospectively identified 158 cases with colorectal adenoma and 203 polyp-free controls who were frequency-matched according to age, sex, race, and time of blood draw. Exposure information was collected using a questionnaire and fasting plasma samples were obtained before the colonoscopy. We used Luminex bead-based multiplex assays to determine level of biomarkers. Multivariate logistic regression model was used to estimate odds ratio (OR) and its 95% confidence interval (CI). Cases had insignificant lower levels of sRAGE, and higher levels of EGF and VEGF than controls. When the highest compared with the lowest category, the OR (95% CI) of colorectal adenoma was 0.55 (0.31-0.96) (P trend = 0.03) for sRAGE and 1.75 (1.05-2.93) (P trend =0.04) for VEGF, adjusting for age, smoking status, hypertension and type 2 diabetes. The inverse association between sRAGE and colorectal adenoma was seen only among those without hypertension (P interaction = 0.02). An inverse association between sRAGE and colorectal adenoma was in line with an inverse association between sRAGE and colorectal cancer previously reported. This study supported the involvement of RAGE-NF-kB related inflammatory mechanism in the formation of colorectal adenoma.
机译:晚期糖基化终产物(RAGE)的受体在通过激活NF-κB促进慢性炎症中起重要作用。可溶形式的RAGE(sRAGE)代表RAGE介导事件的天然竞争抑制剂。在一项基于结肠镜检查的病例对照研究中,我们检查了血浆sRAGE,sTNF-αRI,sTNF-αRII,sIL-6R,EGF,IFNα2,G-CSF,MCP1,TNFβ和VEGF与结直肠风险的相关性腺瘤。我们前瞻性地确定了158例结直肠腺瘤患者和203例无息肉对照患者,这些患者根据年龄,性别,种族和抽血时间进行频率匹配。使用问卷收集暴露信息,并在结肠镜检查之前获得空腹血浆样品。我们使用了基于Luminex磁珠的多重测定来确定生物标志物的水平。使用多元逻辑回归模型估计比值比(OR)及其95%置信区间(CI)。与对照组相比,病例的sRAGE水平较低,而EGF和VEGF水平较高。当与最低类别相比最高时,sRAGE的大肠腺瘤的OR(95%CI)为0.55(0.31-0.96)(P趋势= 0.03)和VEGF的1.75(1.05-2.93)(P趋势= 0.04),调整年龄,吸烟状况,高血压和2型糖尿病。 sRAGE和结直肠腺瘤之间的负相关仅在无高血压的患者中可见(P相互作用= 0.02)。 sRAGE和结直肠腺瘤之间的负相关与先前报道的sRAGE和结直肠癌之间的负相关一致。这项研究支持RAGE-NF-kB相关的炎症机制参与结直肠腺瘤的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号